45results about How to "Improve TCM symptoms" patented technology

The invention discloses a medicine combination for treating impotence and premature ejaculation and a preparation method thereof. The medicine combination is a preparation prepared by the following main raw materials: fried caltrop, acanthopanax, hypericum perforatum, rhodiola and black ants. The medicine combination disclosed by the invention has the effects of soothing liver and tonifying kidney, and tonifying qi and promoting blood circulation and removing obstruction in channels, and has the advantages that the curative effect is exact, the price is cheap, no side effects are produced, the erectile function of a patient can be quickly improved, the hardness of the erection is increased, the erection duration and the ejaculatory latency are prolonged, the total effective rate is 88%, the total effectual rate is 68%, and the clinical curative rate is 28%. The invention also discloses a preparation method of the medicine combination. In the preparation method, according to the different characteristics of traditional Chinese medicines, the traditional Chinese medicines are preprocessed respectively through grinding or solvent extraction, and other methods, and are then proportioned to be prepared into the product.

The invention discloses a traditional Chinese medicine compound for treating spleen and kidney yang deficiency type constipation. The compound is prepared from the following raw materials in parts by weight: 20-40 parts of desertliving cistanche, 20-40 parts of herba epimedii, 6-12 parts of cinnamon, 10-20 parts of ginger processed pinellia, 10-20 parts of cortex magnoliae officinalis, 20-40 parts of allium macrostemon, 20-40 parts of kudzu root, 20-40 parts of tuckahoe and 30-60 parts of angelica. The traditional Chinese medicine compound provided by the invention is prepared according to traditional Chinese medicine theory and pathogenesis of spleen and kidney yang deficiency type constipation, the proportions of the ingredients are scientific and reasonable, as shown in a clinic result, the effective rate of constipation patients is 88% after taking the traditional Chinese medicine compound provided by the invention for two treatment courses, the constipation symptom severity (Wexner grade) is greatly reduced, and the severe constipation proportion is greatly reduced; the living quality (PAC-QOL scale) of constipation patients before and after the treatment has great difference at four dimensions and various dimensions, thereby expressing an excellent treatment effect on the spleen and kidney yang deficiency type constipation, and as shown in experimental investigation, the traditional Chinese medicine compound is free of untoward effects and is safe and effective in clinical use.

The invention provides a Chinese herbal preparation for clearing heat, reducing swelling and relieving pain, which is an external preparation. The Chinese herbal preparation comprises the following active components in parts by weight: 5-30 parts of cortex phellodendri, 2-20 parts of coptis chinensis, 5-30 parts of rheum officinale, 12-50 parts of gypsum, 2-20 parts of borneol, 12-50 parts of purslane, 12-50 parts of herba siegesbeckiae, 5-30 parts of pharbitis seeds, 5-30 parts of radix stephaniae tetrandrae, 5-30 parts of semen lagenariae sicerariae, 5-30 parts of poria peel, 5-30 parts of mirabilite, 12-50 parts of clematis roots and 12-50 parts of rhizoma corydalis. The Chinese herbal preparation is locally applied to the outside of joints, can remarkably relieve inflammation of joints, caused by trauma or rheumatism, has favorable curative effects of clearing heat, reducing swelling, smoothing veins and relieving pain, can further improve Chinese medicine symptoms (such as thirst, restlessness sweating and deep-colored urine) of dampness-heat blockage type arthritis patients, has less adverse effects, and is free from allergic eruption and blister, allergic reaction, light sensitization reaction and the like.

The invention relates to the technical field of traditional Chinese medicines and specifically discloses a traditional Chinese medicine composition for treating a chronic digestive disease associatedwith an anxiety and depression status. The traditional Chinese medicine composition for treating the chronic digestive disease associated with the anxiety and depression status comprises radix codcnopsitis pilosulas, roasted rhizoma atractylodis macrocephalae, white poria, pericarpium citri reticulatae, radix glycyrrhizae, radix bupleuri, fructus aurantii, rhizoma cyperi, radix paeoniae alba, radix ophiopogonis, radix rehmanniae, poria with hostwood and calcined oyster shells. The invention further discloses a purpose of the traditional Chinese medicine composition for treating the chronic digestive disease associated with the anxiety and depression status. The traditional Chinese medicine composition for treating the chronic digestive disease associated with the anxiety and depression status, disclosed by the invention, has the advantages that TCM symptoms, life qualities and the anxiety and depression statuses of liver-stagnation and spleen-deficiency type FD, IBS-D and CHB patientswith the anxiety and depression statuses can be obviously improved through the combination of the traditional Chinese medicine composition and simple basal treatment; the treatment effect of the traditional Chinese medicine composition is superior to those of control groups of a combined and simple basal treatment group and a simple basal treatment group; the traditional Chinese medicine composition is safe in clinical use; and no toxic reaction is found. It is preliminarily proved by clinical research that the traditional Chinese medicine composition can treat three liver-stagnation and spleen-deficiency type chronic diseases combined with the anxiety and depression statuses to achieve an effect of treating different diseases with a same method; therefore, the science and the feasibilityof treating different diseases with the same method in the traditional Chinese medical science are proved.

The invention belongs to the field of the medical technology, and particularly relates to traditional Chinese medicine for treating chronic superficial gastritis combined chronic pharyngitis. The traditional Chinese medicine includes the following traditional Chinese medicine bulk drugs of 8-16 parts of ginseng, 8-16 parts of astragalus membranaceus, 8-16 parts of Chinese yams, 8-16 parts of Chinese dates, 8-16 parts of radix glehniae, 8-16 parts of adenophora tetraphylla, 8-16 parts of platycodon grandiflorum, 4-8 parts of boat-fruited scaphium seeds, 4-8 parts of mint, 5-13 parts of orange peel, 5-13 parts of costusroot and 4-8 parts of liquorice. The traditional Chinese medicine can obviously improve traditional Chinese medicine symptoms and gastroscope pathological findings of patients, and the good clinical effect is achieved.

The invention belongs to the technical field of traditional Chinese medicines, and relates to a medicine composition for treating recurrent abortion and a method for preparing the medicine composition. The medicine composition comprises fructus lycii, semen cuscutae, fructus broussonetiae, dried radix rehmanniae, cortex moutan, viola japonica, fruits of herba melastomatis dodecandri, cortex eucommiae, semen plantaginis, fructus alpiniae oxyphyllae and rhizoma atractylodis macrocephalae according to certain weight proportions. The medicine composition and the method have the advantages that various medicines are compatible with one another, effects of tonifying kidneys, clearing livers, nourishing and activating blood, consolidating thoroughfare and conception channels and preventing miscarriage can be realized by the aid of meaning of ' same source of livers and kidneys and joint treatment on the livers and the kidneys', ACA (anticardiolipin antibodies) can become negative by means of immunological regulation, fetuses can continue developing, the blood viscosity can be obviously reduced, the circulation flow rates can be increased, platelet aggregation and thrombosis can be resisted, placental micro-circulation can be improved, traditional Chinese medicine symptoms of patients can be treated, and the shortcoming of adverse factors of simple western medicine therapy can be overcome.

The invention discloses a traditional Chinese medicine compound for treating spleen and kidney yang deficiency type constipation. The compound is prepared from the following raw materials in parts by weight: 20-40 parts of desertliving cistanche, 20-40 parts of herba epimedii, 6-12 parts of cinnamon, 10-20 parts of ginger processed pinellia, 10-20 parts of cortex magnoliae officinalis, 20-40 parts of allium macrostemon, 20-40 parts of kudzu root, 20-40 parts of tuckahoe and 30-60 parts of angelica. The traditional Chinese medicine compound provided by the invention is prepared according to traditional Chinese medicine theory and pathogenesis of spleen and kidney yang deficiency type constipation, the proportions of the ingredients are scientific and reasonable, as shown in a clinic result, the effective rate of constipation patients is 88% after taking the traditional Chinese medicine compound provided by the invention for two treatment courses, the constipation symptom severity (Wexner grade) is greatly reduced, and the severe constipation proportion is greatly reduced; the living quality (PAC-QOL scale) of constipation patients before and after the treatment has great difference at four dimensions and various dimensions, thereby expressing an excellent treatment effect on the spleen and kidney yang deficiency type constipation, and as shown in experimental investigation, the traditional Chinese medicine compound is free of untoward effects and is safe and effective in clinical use.

The invention discloses a medicinal composition containing Radix Paeoniae Alba for treating apoplexy and its preparation. The pharmaceutical composition of the present invention is a pure Chinese medicine preparation made from Gastrodia elata, Radix Paeoniae Alba, Bombyx mori, Ophiopogon japonicus, and Angelica. It has been proved by clinical trials that the pharmaceutical composition of the present invention has the effects of calming the liver and quenching wind, nourishing yin and suppressing yang, and is suitable for Stroke, especially the treatment of patients with yin deficiency and wind movement syndrome.

The invention discloses a medicinal composition for treating apoplexy containing antelope horn and its preparation. The pharmaceutical composition of the present invention is a pure traditional Chinese medicine preparation made from Gastrodia elata, antelope horn, Fangfeng, notopterygium, and Ophiopogon japonicus. Clinical trials have proved that the pharmaceutical composition of the present invention has the effects of cooling the liver and quenching wind, benefiting yin and dredging collaterals, and is suitable for apoplexy Diseases, especially the treatment of patients with yin deficiency and wind movement syndrome.

The invention relates to a health-preserving coffee and a traditional Chinese medicine composition for people with metabolic syndrome of deficiency of both qi and yin. The health-preserving coffee or traditional Chinese medicine composition is made of the following raw materials in parts by weight: 5-7 parts of Radix Pseudostellariae, 2-4 parts of Pueraria Radix, 0.5-2 parts of Peppermint, and 8-10 parts of coffee. Animal experiments show that for the rat model of metabolic syndrome induced by high fat and high salt, the traditional Chinese medicine health-preserving coffee of the present invention combined with conventional hypoglycemic drugs can significantly reduce blood lipid and blood sugar levels, especially in the regulation of blood lipid. Clinical trials have shown that it can improve the TCM symptoms of metabolic syndrome of both qi and yin deficiency, and reduce triglyceride and cholesterol levels. The invention is helpful to avoid the aggravation of Qi and Yin deficiency symptoms caused by drinking coffee and staying up late, and the medication is precise and effective in alleviating fatigue, thirst, irritability and other symptoms and lowering blood lipid levels, and has less raw material composition and is easy to prepare Advantage.

The invention relates to a traditional Chinese medicine composition for treating chronic bronchitis. The traditional Chinese medicine is prepared from, by weight, 10-20 parts of cortex mori radicis, 10-20 parts of mulberry leaves, 15-21 parts of scutellaria baicalensis, 3-9 parts of roasted ephedra herbs, 6-12 parts of radix adenophorae, 6-12 parts of radix ophiopogonis, 6-12 parts of apricot kernels, 1-5 parts of platycodon grandiflorus, 10-20 parts of rhizoma phragmitis and 3-9 parts of licorice roots. The clinical curative effect of the traditional Chinese medicine composition on treating chronic-bronchitis phlegm-heat by stagnating the lung is obvious, the traditional Chinese medicine composition has the obvious advantage in the curative effect aspect of traditional-Chinese-medicine syndrome treating, related laboratory indexes can be obviously improved, the high clinical application value is achieved, and the traditional Chinese medicine composition is worthy of being further popularized in clinic.

The invention discloses formula essential oil for treating hyperplasia of mammary glands. The formula essential oil is compounded from rose essential oil, mint essential oil, evening primrose essential oil, sweet orange essential oil and Jojoba oil, wherein the mint essential oil is used as a penetration enhancer, and transdermic absorption is achieved. As an external use medicine for treating cyclomastopathy, the formula essential oil greatly increases the use comfort degree, and abuses of oral medicines are avoided. During clinical testing, VAS score, tumor size score, tumor texture score and traditional Chinese medicine syndrome score of a rose and mint breast relieving essential oil treatment group are obviously reduced than those before treatment, but have significant differences, which indicates that the rose and mint breast relieving essential oil has significant treatment effects in the respects of alleviating breast pain, narrowing lumps in the breast, improving tumor textureand improving traditional Chinese medical science symptoms, the total effective rate of clinic curative effects is 100%, and the clinic curative effects are good.

The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicine for treating ankylosing spondylitis secondary osteoporosis and a preparation method of the traditional Chinese medicine. The traditional Chinese medicine for treating ankylosing spondylitis secondary osteoporosis is prepared from the following traditional Chinese medicines in parts by weight: 15-25 parts of leonurus, 25-35 parts of Chinese angelica, 25-35 parts of ginseng, 25-35 parts of astragalus membranaceus, 25-35 parts of deer-horn glue, 25-35 parts of turtle shell glue, 25-35 parts of the fruit of Chinese wolfberry, 15-25 parts of radix paeoniae alba, 15-25 parts of pseudo-ginseng, 15-25 parts of lumbricus, 15-25 parts of stiff silkworm, 9-15 parts of prepared frankincense, 9-15 parts of prepared myrrh, 15-25 parts of wadalee-gum-tree, 25-35 parts of the root of bidentate achyranthes, 15-25 parts of rheum officinale, 15-25 parts of kadsura root-bark, 15-25 parts of cassia twig, 15-25 parts of poria cocos, and 15-25 parts of sea horse. The Traditional Chinese medicine disclosed by the invention has the effects of supplying vital essence and marrow, enriching blood, invigorating the circulation of blood, dispersing blood stasis and dredging collaterals and can be used for clinically treating ankylosing spondylitis secondary osteoporosis, and therefore, the ankylosing spondylitis symptom can be improved while bone mineral density is increased.

The invention relates to the technical field of traditional Chinese medicine, and specifically discloses a traditional Chinese medicine composition for treating chronic digestive tract diseases accompanied by anxiety and depression, including codonopsis codonopsis, fried Atractylodes macrocephala, white poria cocos, tangerine peel, licorice, bupleurum, aurantium citrus, Cyperus cyperi, Paeoniae Alba, Ophiopogon japonicus, Shengdi, Fushen and calcined oyster. The invention also discloses the application of the above-mentioned traditional Chinese medicine composition. The traditional Chinese medicine composition of the present invention combined with simple basic treatment can significantly improve the related Chinese medicine symptoms, quality of life and anxiety and depression state of patients with liver depression and spleen deficiency type FD, IBS-D, CHB with anxiety and depression, and its curative effect is better than that of the control group combined with simple basic treatment The treatment group and the simple basic treatment group were safe in clinical use, and no toxic reactions were found. Through clinical research, this topic preliminarily proves that the traditional Chinese medicine composition of the present invention can treat three chronic diseases of liver depression and spleen deficiency combined with depression and anxiety, and achieve the effect of "treating different diseases with the same treatment", thus proving the scientific nature of "treating different diseases with the same treatment" in traditional Chinese medicine. feasibility.

The invention discloses a traditional Chinese medicine composition for treating blood deficiency and blood stasis type cervical spondylosis, a preparation and application. The traditional Chinese medicine composition is prepared from, by weight, 15-30 g of angelica sinensis and 10-15 g of ligusticum wallichii. 15-20 g of prepared rhizome of rehmannia and 10-15 g of radix paeoniae The traditional Chinese medicine is prepared from 10-20 g of cassia twigs, 10-20 g of ramulus mori, 15-30 g of And 3-9g of honey-fried licorice root. The traditional Chinese medicine for treating the blood deficiency and blood stasis type cervical spondylosis is intended to enrich blood, activate blood, remove blood stasis and dredge collaterals. Angelica sinensis and Ligusticum wallichii are used for promoting qi and activating blood to serve as monarch drugs to replenish blood without stagnation, regulate meridians and collaterals and qi and blood to relieve discomfort such as local pain and numbness, and cassia twig, ramulus mori, radix puerariae and the like are used for promoting blood circulation to relax tendons and dredge collaterals, so that the whole formula has the effects of promoting blood circulation to dissipate blood stasis, and all the drugs are used for tonifying without stagnation. The traditional Chinese medicine is precise and appropriate in compatibility, can quickly relieve numbness symptoms of upper limbs, shoulders and necks after being taken, relieves a muscle tension state, protects the stomach, promotes the secretion of saliva or body fluid and prevents a source of injury to qi and blood biochemistry. The total effective rate of the traditional Chinese medicine symptom treatment effect of the traditional Chinese medicine composition is 84.37%, the total effective rate of a control group is only 63.33%, and the treatment effect of the traditional Chinese medicine composition is remarkably superior to that of a western medicine control group in the aspect of treating blood deficiency and blood stasis type cervical spondylosis.

The present invention is a traditional Chinese medicine compound for treating angina pectoris caused by diffuse coronary disease, which comprises the raw materials of the following components by weight: Astragalus 15-45g, Ophiopogon japonicus 10-30g, Rhizoma Chuanxiong 9-15g, Hirudo 6-9g, Pueraria mirifica 15g ~30g, Forsythia 9~18g, Coptidis 9~15g, Gardenia 6~18g, Guizhi 9~27g, Radix Paeoniae Alba 9~27g, Licorice 6~12g; any one or more of the following raw materials can be included Combination: Schisandra 6-15g, Scutellaria baicalensis 6-15g, Yuanhu 10-30g, Panax notoginseng powder 2-6g and Codonopsis 12-30g. For the treatment of diffuse coronary lesions, it can clearly show the myocardial ischemia and angina symptoms of patients, and solve the embarrassing problem that current clinical western medicine cannot perform coronary blood flow reconstruction for this disease. The treatment method is simple and easy, and there is no adverse reaction. The curative effect is exact.

The invention discloses a radix achyranthis bidentatae containing medicine composition for treating stroke and a preparation thereof. The medicine composition disclosed by the invention is a pure traditional Chinese medicine preparation prepared from gastrodia elata, radix achyranthis bidentatae, succus bambusae, arisaema cum bile, and rhizoma arisaematis. Clinical assays prove that the medicine composition disclosed by the invention has the efficacies of dispelling wind, reducing phlegm, dredging collaterals and inducing resuscitation, and is especially suitable for the treatment of a patient suffering from the stroke, and especially a patient suffering from wind-phlegm blocking collaterals.